Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q2 2019 Aptose Biosciences Inc Earnings Call Transcript

Aug 06, 2019 / 09:00PM GMT
Release Date Price: $35.1 (+2.63%)
Operator

Good afternoon. My name is Chris and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for the Second Quarter ended June 30, 2019. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. (Operator Instructions) As a reminder, this conference call may be recorded.

I would like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Chris. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the second quarter ended June 30, 2019. I am Susan Pietropaolo, Communications Representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Mr. Gregory Chow, Executive Vice President and Chief Financial Officer; and Dr. Jotin Marango, Senior Vice President and Chief Business Officer.

Before we proceed, I would like to remind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot